CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, today announced its participation in the Wedbush 2012 Life Sciences: Management Access Conference at Le Parker Meridien in New York City, NY, presenting on Wednesday, August 15th at 3:40 PM.
